Eli Lilly and Company (LLY) on Monday announced that it would acquire a small biopharmaceutical startup that develops cancer treatment, Loxo Oncology
Bristol-Myers Squibb Co.
-(BMY)
XNYS:BMY
Bristol-Myers Squibb swallows Celgene for $74-bln; Celgene stock surges
Bristol-Myers Squibb (NYSE: BMY) acquired its peer Celgene (NASDAQ: CELG) in a $74-billion cash-and-stock deal. Under the agreement terms, Celgene shareholders will